STOCK TITAN

Sientra to Present at the William Blair 40th Annual Growth Stock Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Sientra, a medical aesthetics company, will participate in a virtual fireside chat at the William Blair 40th Annual Growth Stock Conference on June 9, 2020, at 2:00 p.m. CDT. The audio webcast will be accessible via the investor relations section of Sientra's website. Sientra is known for its innovative products like the OPUS breast implants and miraDry system, aimed at enhancing patients' body image and self-esteem. A replay of the chat will be available for 90 days following the event.

Positive
  • None.
Negative
  • None.

Insights

Analyzing...

SANTA BARBARA, Calif., June 02, 2020 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN), a medical aesthetics company, announced today that members of management will participate in a virtual fireside chat at the William Blair 40th Annual Growth Stock Conference. The fireside chat will take place on Tuesday, June 9, 2020 at 2:00 p.m. CDT.

Event: William Blair 40th Annual Growth Stock Conference
Date: Tuesday, June 9, 2020
Time: 2:00 p.m. CDT
                                     
An audio webcast of the Company’s fireside chat will be made available on the investor relations section of Sientra’s website at http://www.sientra.com. A replay of the presentation will be available for 90 days.

About Sientra
Headquartered in Santa Barbara, California, Sientra is a diversified global medical aesthetics company and a leading partner to aesthetic physicians. The Company offers a suite of products designed to make a difference in patients' lives by enhancing their body image, growing their self-esteem, and restoring their confidence. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company’s Breast Products Segment includes its OPUS® breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM® the #1 performing, preferred and recommended scar gel of plastic surgeons(*). The Company’s miraDry Segment, comprises its miraDry® system, which is approved for sale in over 40 international markets, and is the only non-surgical FDA-cleared device for the permanent reduction of underarm sweat, odor and hair of all colors.

Sientra uses its investor relations website to publish important information about the Company, including information that may be deemed material to investors. Financial and other information about Sientra is routinely posted and is accessible on the Company’s investor relations website at www.sientra.com.

(*) Data on file

Contact
Investor Relations
805-679-8885


FAQ

When will Sientra participate in the William Blair Growth Stock Conference?

Sientra will participate in the William Blair 40th Annual Growth Stock Conference on June 9, 2020, at 2:00 p.m. CDT.

How can I access the Sientra fireside chat audio webcast?

The audio webcast of Sientra's fireside chat will be available on the investor relations section of their website at www.sientra.com.

How long will the replay of Sientra's presentation be available?

A replay of Sientra's fireside chat presentation will be available for 90 days after the event.

What are some key products offered by Sientra?

Sientra offers notable products such as OPUS breast implants and the miraDry system for underarm sweat reduction.

Where is Sientra headquartered?

Sientra is headquartered in Santa Barbara, California.
Sientra, Inc.

NASDAQ:SIEN

SIEN Rankings

SIEN Latest News

SIEN Stock Data

2.08M
11.05M
9.61%
17.04%
10.94%
Medical Devices
Healthcare
Link
United States
Irvine